Tumors in this population tend to be slow-growing and asymptomatic, so early detection may carry more risks than benefits, the panel concluded.
"Screening patterns couldn't have been more similar before and after," says lead researcher Scott E. Eggener, M.D., an assistant professor of surgery at the University of Chicago Medical Center.
(Buffet, for his part, has elected to undergo radiation.)
The media coverage surrounding the 2008 guidelines has been hard to miss, he says, and although there may be a "subset" of specialists who are "consciously or unconsciously" overscreening and overtreating their patients, most PSA tests are ordered by primary care physicians with no financial stake in a diagnosis.
Even among men in the 75-and-over bracket, Eggener says, screening might make sense for certain patients.
"It's very reasonable to check PSA levels, because it might save that guy's life," he says.